The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries

The docking protein p140Cap negatively regulates tumour cell features. Its relevance on breast cancer patient survival, as well as its ability to counteract relevant cancer signalling pathways, are not fully understood. Here we report that in patients with ERBB2 -amplified breast cancer, a p140Cap-p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications 2017-03, Vol.8 (1), p.14797-14797, Article 14797
Hauptverfasser: Grasso, Silvia, Chapelle, Jennifer, Salemme, Vincenzo, Aramu, Simona, Russo, Isabella, Vitale, Nicoletta, Verdun di Cantogno, Ludovica, Dallaglio, Katiuscia, Castellano, Isabella, Amici, Augusto, Centonze, Giorgia, Sharma, Nanaocha, Lunardi, Serena, Cabodi, Sara, Cavallo, Federica, Lamolinara, Alessia, Stramucci, Lorenzo, Moiso, Enrico, Provero, Paolo, Albini, Adriana, Sapino, Anna, Staaf, Johan, Di Fiore, Pier Paolo, Bertalot, Giovanni, Pece, Salvatore, Tosoni, Daniela, Confalonieri, Stefano, Iezzi, Manuela, Di Stefano, Paola, Turco, Emilia, Defilippi, Paola
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The docking protein p140Cap negatively regulates tumour cell features. Its relevance on breast cancer patient survival, as well as its ability to counteract relevant cancer signalling pathways, are not fully understood. Here we report that in patients with ERBB2 -amplified breast cancer, a p140Cap-positive status associates with a significantly lower probability of developing a distant event, and a clear difference in survival. p140Cap dampens ERBB2-positive tumour cell progression, impairing tumour onset and growth in the NeuT mouse model, and counteracting epithelial mesenchymal transition, resulting in decreased metastasis formation. One major mechanism is the ability of p140Cap to interfere with ERBB2 -dependent activation of Rac GTPase-controlled circuitries. Our findings point to a specific role of p140Cap in curbing the aggressiveness of ERBB2 -amplified breast cancers and suggest that, due to its ability to impinge on specific molecular pathways, p140Cap may represent a predictive biomarker of response to targeted anti-ERBB2 therapies. p140Cap adaptor proteins interfere with adhesion and growth factor-dependent signalling in cancer cells but the mechanisms are unclear. Here the authors show that p140Cap interferes with ERBB2-dependent activation of Rac GTPase-controlled circuitries reducing metastasis and cancer progression.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms14797